Advisory Board
Ulrich Pessara
Dr. Ulrich Pessara has broad experience in business transactions in the Pharmaceutical and Biotech industries. In 2004, he became General Partner with JSB Partners, an international transaction advisory firm based in New York, Zurich and Munich, and is currently Managing Director of the Company’s Swiss office. In this function, he was closing Pharma deals with various international players in a total value of more than US$ 700 million. From 2000 to 2004, he was a co-founder and COO of Xantos Biomedicine, a Munich based Biotech Company, where he was responsible for business development, intellectual property and strategic planning. From 1997 to 2000, he was responsible for international biotech alliances as Director of Program Management at Hofmann-La Roche based in Penzberg/Germany. In 1991, he started his Pharma career with Boehringer Mannheim where he was responsible for biopharmaceutical drug development with several international Biotech companies. In this function, he has also served as Managing Director and a board member in several international joint venture Biotech companies in San Diego-USA, Milan-Italy and Hanover-Germany. Formerly, Dr Pessara had an established scientific career in molecular immunology that spanned more than ten years and received his PhD at the University of Heidelberg/Germany.
Eduardo Flores Bermudez
Eduardo Flores Bermudez is a physician trained in Neurological Surgery (Bonn, Germany) and specialized in Pharmaceutical Medicine. His Business Education, MBA dual award, is from the British-German program (Berlin-Cambridge). With over two decades of experience in the Pharmaceutical Industry his expertise ranges from Clinical Development, Medical Affairs, through Strategic Marketing and International Brand Management to Competitive Intelligence. He has been a Scholar of the German Academic Exchange (DAAD) from 1985 to 1988 and joined Bayer Schering Pharma (formerly Schering AG) in late 1988. Career path: R&D Clinician, Medical Affairs Clinician, International Brand Manager (Strategy and Product Management), leading CI projects since 1997. He is a Lecturer for Strategic Marketing & Competitive Intelligence at the European Center for Pharmaceutical Medicine, Basel, Switzerland. Being elected into the Board of Directors of the Society of Competitive Intelligence Professionals in 2007 he is currently the President of this Society.
Erik Hoppe
Erik Hoppe studied Chemistry with emphasis on Biochemistry as well as Business Administration and Japanese Studies. After doing his PhD in Bioscience with Prof. Voker A. Erdmann and Dr. Jens-Peter Fürste, the initiator of NOXXON Pharma, Dr. Hoppe worked as a freelancer for a holding company. Following that he worked as an interim managing director for a Biotech company and founded Bioventure Consulting in Göttingen. Dr. Hoppe is accredited as a consultant for the kfw Mittelstandsbank (SME bank) and as a coach for founders of a new business at the High-Tech Gründerfonds. Furthermore he is a partner in several Biotechnology companies and advisory board member of the Jennewein Biotechnologie GmbH and expert for the German Federal Ministry of Education and Research.
